Search results
Trial data support non-antibiotic treatment for bacterial vaginosis
Center for Infectious Disease Research and Policy· 5 days agoThe trial investigated the efficacy of the broad-spectrum antiseptic dequalinium chloride for...
Women need better treatments for bacterial vaginosis: Researchers call for studies for a treatment...
Medical Xpress· 6 days agoDQC—an antiseptic—has been in use for several decades in countries throughout Europe as an alternative treatment for BV. It is not currently approved by the U.S. Food and ...
Autism Spectrum Disorder (ASD)
Health via Yahoo News· 6 days agoAutism spectrum disorder (ASD) is a neurodevelopmental condition that causes brain differences that can affect your emotions, behavior, and social...
Vaginal thrush: What's up 'down there'?
dpa international via Yahoo News· 5 days agoWith symptoms that include itching and burning, vaginal thrush is no fun. Many women are understandably reluctant to talk about it, although medical...
Daré Bioscience (NASDAQ:DARE) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 5 days agoDaré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued on Wednesday, Benzinga reports. They presently ...
Equities Analysts Offer Predictions for Hologic, Inc.’s Q3 2024 Earnings (NASDAQ:HOLX)
ETF DAILY NEWS· 13 hours agoHologic, Inc. (NASDAQ:HOLX – Free Report) – Leerink Partnrs decreased their Q3 2024 EPS estimates for shares of Hologic in a research note issued to investors on Thursday, May 2nd. Leerink Partnrs ...
Hologic (NASDAQ:HOLX) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS
ETF DAILY NEWS· 3 days agoHologic (NASDAQ:HOLX – Get Free Report) posted its quarterly earnings data on Thursday. Hologic had a return on equity of 18.81% and a net margin of 11.78%. The company’s revenue for the quarter ...